Five-Year Outcomes of a Cohort of HIV-Infected Injection Drug Users in a Primary Care Practice

References

• Hogg , R S , Yip , B Kully , C . 1999 . Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens . CMAJ , 160 : 659 – 665 .
   PubMed Web of Science ®Google Scholar
• Loiue , J K , Hsu , L C , Osmond , D H , Katz , M H and Schwarcz , S K . 2002 . Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994–1998 . J Infect Dis , 186 : 1023 – 1027 .
   PubMedGoogle Scholar
• Whitman , S , Murphy , J , Cohen , M and Sherer , R . 2000 . Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults and injection drug users, from 1995–1997 . Arch Intern Med , 160 : 365 – 369 .
   PubMed Web of Science ®Google Scholar
• Mocroft , A , Ledergerber , B Katlama , C . 2003 . EuroSIDA study group. Decline in the AIDS and death rates in the EuroSIDA study: an observational study . Lancet , 362 : 22 – 29 .
   PubMed Web of Science ®Google Scholar
• Moore , R D and Chaisson , R E . 1999 . Natural history of HIV infection in the era of combination antiretroviral therapy . AIDS , 13 : 1933 – 1942 .
   PubMed Web of Science ®Google Scholar
• Palella , F J , Delaney , K M Moorman , A C . 1998 . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection . N Engl J Med , 338 : 853 – 860 .
   PubMed Web of Science ®Google Scholar
• Palepu , A , Yip , B Miller , C . 2001 . Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use . AIDS , 15 : 423 – 424 .
   PubMed Web of Science ®Google Scholar
• Poundstone , K E , Chaisson , R E and Moore , R D . 2001 . Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy . AIDS , 15 : 1115 – 1123 .
   PubMed Web of Science ®Google Scholar
• Zaccarelli , M , Barracchini , A De Longis , P . 2002 . Factors related to virologic failure among HIV-positive injecting drug users treated with combination antiretroviral therapy including two nucleoside reverse transcriptase inhibitors and nevirapine . AIDS Patient Care STDS , 16 : 67 – 73 .
   PubMed Web of Science ®Google Scholar
• Lucas , G M , Cheever , L W , Chaisson , R E and Moore , D . 2001 . Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection . J Acquir Immune Defic Syndr , 27 : 251 – 259 .
   PubMed Web of Science ®Google Scholar
• Cohen , J A . 2002 . HIV-1 infection in injection drug users . Infect Dis Clin North Am , 16 : 745 – 770 .
   PubMedGoogle Scholar
• Selwyn , P A , Alcabes , P A Hartel , D M . 1992 . Clinical manifestations and predictors of disease progression in injecting drug users with human immunodeficiency virus infection . N Engl J Med , 327 : 1697 – 1703 .
   PubMed Web of Science ®Google Scholar
• Chaisson , R E , Keruly , J C and Moore , R D . 1995 . Race, sex, drug use, and progression of human immunodeficiency virus disease . N Engl J Med , 333 : 751 – 756 .
   PubMed Web of Science ®Google Scholar
• Celentano , D D , Vlahov , D , Cohn , S , Shadle , V M , Obasanjo , O and Moore , R D . 1998 . Self-reported antiretroviral therapy in injection drug users . JAMA , 280 : 544 – 546 .
   PubMed Web of Science ®Google Scholar
• Celentano , D D , Galai , N Sethi , A K . 2001 . Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users . AIDS , 15 : 1707 – 1715 .
   PubMed Web of Science ®Google Scholar
• Lucas , G M , Gebo , K A , Chaisson , R E and Moore , R D . 2002 . Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic . AIDS. , 16 Mar 29 : 767 – 774 .
   PubMed Web of Science ®Google Scholar
• Mocroft , A , Madge , S Johnson , A M . 1999 . A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival . J Acquir Immune Defic Syndr , 22 : 369 – 378 .
   PubMed Web of Science ®Google Scholar
• Stein , M D , Rich , J D Maksad , J . 2000 . Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use . Am J Drug Alcohol Abuse , 26 : 195 – 205 .
   PubMed Web of Science ®Google Scholar
• Wood , E , Schechter , M T , Tyndall , M W , Montaner , J S , O'Shaughnessy , M V and Hogg , R S . 2000 . Antiretroviral medication use among injection drug users: two potential futures . AIDS , 14 : 1229 – 1235 .
   PubMed Web of Science ®Google Scholar
• Palepu , A , Tyndall , M , Yip , B , O'Shaughnessy , M V , Hogg , R S and Montaner , J S . 2003 . Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use . J Acquir Immune Defic Syndr , 32 : 522 – 526 .
   PubMed Web of Science ®Google Scholar
• Wood , E , Montaner , J S Yip , B . 2003 . Adherence and plasma HIV RNA responses to highly active anti-retroviral therapy among HIV-1 infected injection drug users . CMAJ , 169 : 656 – 661 .
   PubMed Web of Science ®Google Scholar
• O'Connor , P G , Molde , S , Henry , S , Shockcor , W T and Schottenfeld , R S . 1992 . Human immunodeficiency virus infection in intravenous drug users: a model for primary care . Am J Med , 93 : 382 – 386 .
   PubMed Web of Science ®Google Scholar
• Rastegar , D A , Fingerhood , M I and Jasinski , D R . 2003 . Highly active antiretroviral therapy outcomes in a primary care clinic . AIDS Care , 15 : 231 – 237 .
   PubMed Web of Science ®Google Scholar
• Pol , S , Lamorthe , B Thi , N T . 1998 . Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users . J Hepatol , 28 : 945 – 950 .
   PubMed Web of Science ®Google Scholar
• Romes , R , Rumi , M G Donato , M F . 2000 . Hepatitis C is more severe in drug users with human immunodeficiency virus infection . J Viral Hep , 7 : 297 – 301 .
   PubMedGoogle Scholar
• Sulkowski , M S , Moore , R D , Mehta , S H , Chaisson , R E and Thomas , D L . 2002 . Hepatitis C and progression of HIV disease . JAMA , 288 : 199 – 206 .
   PubMed Web of Science ®Google Scholar
• Sulkowski , M S and Thomas , D L . 2003 . Hepatitis C in the HIV-infected person . Ann Intern Med , 138 : 197 – 207 .
   PubMed Web of Science ®Google Scholar
• Tedaldi , E M , Baker , R K Moorman , A C . 2003 . Influence of Coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy . Clin Infect Dis , 36 : 363 – 367 .
   PubMed Web of Science ®Google Scholar
• Vlahov , D , Graham , N Hoover , D . 1998 . Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users . JAMA , 279 : 35 – 40 .
   PubMed Web of Science ®Google Scholar
• Brown , L S , Siddiqui , N S and Chu , A F . 1996 . Natural history of HIV-1 infection and predictors of survival in a cohort of HIV-1 seropositive injecting drug users . J Natl Med Assoc , 88 : 37 – 42 .
   PubMedGoogle Scholar
• Mocroft , A , Brettle , R Kirk , O . 2002 . Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study . AIDS , 16 : 1663 – 1671 .
   PubMed Web of Science ®Google Scholar
• Selnes , O A , Galai , N McArthur , J C . 1997 . HIV infection and cognition in intravenous drug users: long-term follow-up . Neurology , 48 : 223 – 230 .
   PubMed Web of Science ®Google Scholar
• Lucas , G M , Chaisson , R E and Moore , R D . 1999 . Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions . Ann Intern Med , 131 : 81 – 87 . 20
   PubMed Web of Science ®Google Scholar
• Arici , C , Ripamonti , D , Ravasio , V , Maggiolo , F , Rizzi , M , Finazzi , M G and Suter , F . 2001 . Long-term clinical benefit after highly active antiretroviral therapy in advanced HIV-1 infection, even in patients without immune reconstitution . Int J STD AIDS , 12 : 573 – 581 .
   PubMedGoogle Scholar
• Deeks , S G , Hecht , F M Swanson , M . 1999 . (1999). HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy . AIDS , 13 : F35 – F43 .
   PubMed Web of Science ®Google Scholar
• Lucas , G M , Weidle , P J , Hader , S and Moore , R D . 2004 . Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study . Clin Infect Dis , 38 ( Suppl 5 ) : S409 – 413 .
   PubMed Web of Science ®Google Scholar
• Conway , B , Prasad , J Reynolds , R . 2004 . Directly observed therapy for the management of HIV-infected patients in a methadone program . Clin Infect Dis , 38 : S402 – 408 .
   PubMed Web of Science ®Google Scholar